vimarsana.com
Home
Live Updates
Small Pharma Reports Financial Results for the Fiscal Year Ended February 28, 2023 and Recent Business Highlights : vimarsana.com
Small Pharma Reports Financial Results for the Fiscal Year Ended February 28, 2023 and Recent Business Highlights
• Multiple clinical milestones achieved including the first proof-of-concept for DMT-based therapies from a blinded placebo-controlled study • Preliminary findings from SPL028 Phase I clinical trial support target drug profile • O...
Related Keywords
Canada ,
London ,
City Of ,
United Kingdom ,
Canadian ,
George Tziras ,
Jenny Maguire ,
Regulatory Agency ,
International Financial Reporting Standards ,
Company Or Small Pharma ,
Small Pharma Inc ,
Company Phase Ib ,
Head Of External Affairs ,
Major Depressive Disorder ,
Depression Rating Scale ,
Proprietary Second Generation Deuterated ,
United States ,
Chief Executive Officer ,
Small Pharma ,
Innovation Passport ,
Investor Relations ,
Chief Executive ,
Markets ,
vimarsana.com © 2020. All Rights Reserved.